2/20
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/20
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/20
09:00 am
gild
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $155.00 price target on the stock.
Low
Report
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $155.00 price target on the stock.
2/19
04:18 pm
gild
Gilead initiated with an Equal Weight at Barclays
Low
Report
Gilead initiated with an Equal Weight at Barclays
2/19
04:18 pm
gild
Gilead initiated with an Equal Weight at Barclays
Low
Report
Gilead initiated with an Equal Weight at Barclays
2/11
12:14 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
12:14 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
10:59 am
gild
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/11
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
08:42 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
08:27 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
08:27 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
07:01 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
07:01 am
gild
Rating for GILD
Medium
Report
Rating for GILD
1/27
09:44 am
gild
Rating for GILD
Low
Report
Rating for GILD
1/27
09:44 am
gild
Rating for GILD
Low
Report
Rating for GILD
1/26
12:47 pm
gild
Rating for GILD
Low
Report
Rating for GILD
1/15
01:03 pm
gild
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/13
11:12 am
gild
Rating for GILD
Low
Report
Rating for GILD
1/13
11:12 am
gild
Rating for GILD
Low
Report
Rating for GILD
1/13
10:59 am
gild
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
1/7
02:47 pm
gild
Rating for GILD
Low
Report
Rating for GILD
1/7
02:47 pm
gild
Rating for GILD
Low
Report
Rating for GILD
1/7
08:55 am
gild
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $145.00 price target on the stock, up previously from $112.00.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $145.00 price target on the stock, up previously from $112.00.